<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib11">
 <label>11</label>
 <element-citation publication-type="journal" id="sref11">
  <person-group person-group-type="author">
   <name>
    <surname>Hotchkiss</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Colston</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Yende</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Crouser</surname>
    <given-names>E.D.</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>G.S.</given-names>
   </name>
   <name>
    <surname>Albertson</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab</article-title>
  <source>Intensive Care Med</source>
  <volume>45</volume>
  <issue>10</issue>
  <year>2019</year>
  <fpage>1360</fpage>
  <lpage>1371</lpage>
  <pub-id pub-id-type="doi">10.1007/s00134-019-05704-z</pub-id>
  <pub-id pub-id-type="pmid">31576433</pub-id>
 </element-citation>
</ref>
